Medmira will leave the competitors behind soon! (Video)
It is really frightening to see how many investors and shareholders at Yahoo, Stockhouse and CEO.CA do not read the most important information correctly, do not understand it and completely misinterpret it!
Please turn on your brain and get your DD right! Don't be scared by paid bazers who want to steal your shares cheaply!
Take a close look at the video of Medmira in the appendix and understand the most important differences from "Vertical Flow" to normal, less precise "Lateral Flow" system!
1. The REVEALCOVID-19 ™ total antibody test can detect antibodies to SARS-CoV-2, the virus that causes COVID-19, in human serum, plasma and whole blood.
2. Most serological tests only detect IgG and / or IgM antibodies, while the total antibody test REVEALCOVID-19 ™ with the "Vertical Flow" system developed by Medmira detects all human immunoglobulins, including IgG, IgM and IgA. (An advantage that no competitor has!)
3. The test from Medmira "Revealcovid-19" has already received CE approval for Europe and may immediately be sold to the USA under FDA emergency use authorization while we are waiting for final approval.
4. Vertical Flow has vertical advantages USP's over "lateral flow": (See video!)
-High precision
- Much faster <3.min
-No hook effects
(This will be a huge problem for lateral flow tests in the future!)
-Revealcovid-19 (Vertical Flow) from Medmira can be used in a wide range of applications: clinical, veterinary, agricultural, food, bio-defense and environmental industries, etc.
5. Medmira has the worldwide patent for "Vertical Flow" system! (No competition / No copy / No prototype as with SONA!)
5. Medmira is led by experienced Swiss entrepreneurs (family businesses) who have already invested X millions and are now only starting their big breakthrough with their company!
6. Medmira will be able to sell the test for an affordable price.
7. Medmira has its own product that is already being tested by the FDA and approval will come soon!
8. Medmira has already received FDA on other tests like HIV! It is much more difficult to achieve this FDA than the approval for the COVID-19 test!
They achieved this difficult approval for HIV with the exact same system / patent "Vertical Flow".
It is a top system without competition!
9. No expensive laboratory equipment necessary and therefore faster and cheaper in price.
10. FDA approval now requires more studies than a few weeks ago. It is normal that these new reputable FDA approvals also take a little longer than we analysts and shareholders think!
11. It is better to take your time for a legitimate approval from the FDA than to risk a recall! That speaks for the great management of Medmira! They are professionals!
12. Many tests and companies that have already received FDA approval (too early) are not sure! FDA will retest all tests with its own strict criteria!
Even large companies like Roche and Abbott are no longer safe! You have completed all the first studies (in-house) with just a few tests .. this will be interesting!
Medmira tested with double the number of tests for in-house study and is even above the required values, even with the new strict criteria of the FDA!
Medmira will therefore easily makes the FDA approval!
13. It is more than logical that the last quarterly figures will not improve .. the big jump forward comes with the next company figures! 3.5 million is a perfect start and more than the years before!
With Medmira you will be a very happy shareholder! Nice Weekend.
For your Information: Here are the names of poor bashers and short manipulators in all Medmira chat rooms! (Yahoo, Stockhouse, CEO.CA)
-RBC
-Magic 8-Ball Says
-Brett
-Moh
-Farid
-Kurt